These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 16442811)

  • 1. Diphtheria toxoid loaded poly-(epsilon-caprolactone) nanoparticles as mucosal vaccine delivery systems.
    Singh J; Pandit S; Bramwell VW; Alpar HO
    Methods; 2006 Feb; 38(2):96-105. PubMed ID: 16442811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.
    Gupta NK; Tomar P; Sharma V; Dixit VK
    Vaccine; 2011 Nov; 29(48):9026-37. PubMed ID: 21939718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal or systemic administration of rE2 glycoprotein antigen loaded PLGA microspheres.
    Brandhonneur N; Loizel C; Chevanne F; Wakeley P; Jestin A; Le Potier MF; Le Corre P
    Int J Pharm; 2009 May; 373(1-2):16-23. PubMed ID: 19429284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems.
    Mohanan D; Slütter B; Henriksen-Lacey M; Jiskoot W; Bouwstra JA; Perrie Y; Kündig TM; Gander B; Johansen P
    J Control Release; 2010 Nov; 147(3):342-9. PubMed ID: 20727926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally.
    Jaganathan KS; Vyas SP
    Vaccine; 2006 May; 24(19):4201-11. PubMed ID: 16446012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo uptake of an experimental microencapsulated diphtheria vaccine following sub-cutaneous immunisation.
    Peyre M; Fleck R; Hockley D; Gander B; Sesardic D
    Vaccine; 2004 Jun; 22(19):2430-7. PubMed ID: 15193406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen.
    Slütter B; Bal S; Keijzer C; Mallants R; Hagenaars N; Que I; Kaijzel E; van Eden W; Augustijns P; Löwik C; Bouwstra J; Broere F; Jiskoot W
    Vaccine; 2010 Aug; 28(38):6282-91. PubMed ID: 20638455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PLGA:poloxamer and PLGA:poloxamine blend nanostructures as carriers for nasal gene delivery.
    Csaba N; Sánchez A; Alonso MJ
    J Control Release; 2006 Jun; 113(2):164-72. PubMed ID: 16759732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The enhancement of the immune response against S. equi antigens through the intranasal administration of poly-epsilon-caprolactone-based nanoparticles.
    Florindo HF; Pandit S; Lacerda L; Gonçalves LM; Alpar HO; Almeida AJ
    Biomaterials; 2009 Feb; 30(5):879-91. PubMed ID: 19027152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs.
    Dong Y; Feng SS
    Biomaterials; 2005 Oct; 26(30):6068-76. PubMed ID: 15894372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
    Kumar PS; Ramakrishna S; Saini TR; Diwan PV
    Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment.
    Westedt U; Kalinowski M; Wittmar M; Merdan T; Unger F; Fuchs J; Schäller S; Bakowsky U; Kissel T
    J Control Release; 2007 May; 119(1):41-51. PubMed ID: 17346845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and evaluation of novel biodegradable microspheres based on poly(d,l-lactide-co-glycolide) and poly(epsilon-caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket: in vitro and in vivo studies.
    Mundargi RC; Srirangarajan S; Agnihotri SA; Patil SA; Ravindra S; Setty SB; Aminabhavi TM
    J Control Release; 2007 May; 119(1):59-68. PubMed ID: 17331611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of bulk and surface properties of some biocompatible hydrophobic polymers on the stability of methylene chloride-in-water mini-emulsions used to prepare nanoparticles by emulsification-solvent evaporation.
    Babak VG; Baros F; Boulanouar O; Boury F; Fromm M; Kildeeva NR; Ubrich N; Maincent P
    Colloids Surf B Biointerfaces; 2007 Oct; 59(2):194-207. PubMed ID: 17600692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs.
    Win KY; Feng SS
    Biomaterials; 2005 May; 26(15):2713-22. PubMed ID: 15585275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of surface charge of PLGA particles of recombinant hepatitis B surface antigen in enhancing systemic and mucosal immune responses.
    Thomas C; Gupta V; Ahsan F
    Int J Pharm; 2009 Sep; 379(1):41-50. PubMed ID: 19524654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G-CSF loaded biodegradable PLGA nanoparticles prepared by a single oil-in-water emulsion method.
    Choi SH; Park TG
    Int J Pharm; 2006 Mar; 311(1-2):223-8. PubMed ID: 16423477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymeric matrix for drug delivery: honokiol-loaded PCL-PEG-PCL nanoparticles in PEG-PCL-PEG thermosensitive hydrogel.
    Gou M; Gong C; Zhang J; Wang X; Wang X; Gu Y; Guo G; Chen L; Luo F; Zhao X; Wei Y; Qian Z
    J Biomed Mater Res A; 2010 Apr; 93(1):219-26. PubMed ID: 19557789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of in vitro parameters of tamoxifen citrate loaded poly(lactide-co-glycolide), poly(epsilon-caprolactone) and chitosan nanoparticles.
    Cirpanli Y; Yerlikaya F; Ozturk K; Erdogar N; Launay M; Gegu C; Leturgez T; Bilensoy E; Calis S; Capan Y
    Pharmazie; 2010 Dec; 65(12):867-70. PubMed ID: 21284254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination.
    Wang D; Molavi O; Lutsiak ME; Elamanchili P; Kwon GS; Samuel J
    J Pharm Pharm Sci; 2007; 10(2):217-30. PubMed ID: 17706180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.